Cargando…

Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities

Multiple genetic and environmental factors are likely to contribute to the development of Alzheimer's disease (AD). The most important known risk factor for AD is presence of the E4 isoform of apolipoprotein E (apoE). Epidemiological studies demonstrated that apoE4 carriers have a higher risk a...

Descripción completa

Detalles Bibliográficos
Autor principal:	Cedazo-Mínguez, Angel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2007
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401287/ https://www.ncbi.nlm.nih.gov/pubmed/18205697 http://dx.doi.org/10.1111/j.1582-4934.2007.00130.x

Ejemplares similares

Apolipoprotein E, amyloid-ß clearance and therapeutic opportunities in Alzheimer's disease
por: Kline, Adam
Publicado: (2012)

Oxidative Stress in Alzheimer's Disease: Why Did Antioxidant Therapy Fail?
por: Persson, Torbjörn, et al.
Publicado: (2014)

Successful therapies for Alzheimer’s disease: why so many in animal models and none in humans?
por: Franco, Rafael, et al.
Publicado: (2014)

Apolipoprotein E and Alzheimer's disease
por: Troutwine, Benjamin R., et al.
Publicado: (2022)

Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease
por: Williams, Tosha, et al.
Publicado: (2020)

Toward common mechanisms for risk factors in Alzheimer's syndrome
por: Medina, Miguel, et al.
Publicado: (2017)

Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer’s disease?
por: Vecchio, Filomena Lo, et al.
Publicado: (2022)

Apolipoprotein E ε4 magnifies lifestyle risks for dementia: a population-based study
por: Kivipelto, Miia, et al.
Publicado: (2008)

Apolipoprotein E4 Elicits Lysosomal Cathepsin D Release, Decreased Thioredoxin-1 Levels, and Apoptosis
por: Persson, Torbjörn, et al.
Publicado: (2017)

Apolipoprotein E region molecular signatures of Alzheimer's disease
por: Kulminski, Alexander M., et al.
Publicado: (2018)

Apolipoprotein E in Synaptic Plasticity and Alzheimer’s Disease: Potential Cellular and Molecular Mechanisms
por: Kim, Jaekwang, et al.
Publicado: (2014)

Function and Comorbidities of Apolipoprotein E in Alzheimer's Disease
por: Leduc, Valérie, et al.
Publicado: (2011)

Targeting Apolipoprotein E for Alzheimer’s Disease: An Industry Perspective
por: Suidan, Georgette L., et al.
Publicado: (2019)

Necroptosis and Alzheimer’s Disease: Pathogenic Mechanisms and Therapeutic Opportunities
por: Zhang, Ruxin, et al.
Publicado: (2023)

Apolipoprotein A1, the neglected relative of Apolipoprotein E and its potential role in Alzheimer’s disease
por: Endres, Kristina
Publicado: (2021)

Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease
por: Najm, Ramsey, et al.
Publicado: (2019)

Interactions of metals and Apolipoprotein E in Alzheimer’s disease
por: Xu, He, et al.
Publicado: (2014)

Apolipoprotein E as a β-amyloid-independent factor in Alzheimer’s disease
por: Wolf, Andrew B, et al.
Publicado: (2013)

Bibliometric analysis of global research on the role of apolipoprotein E in Alzheimer's disease
por: Wang, Zhanzhang, et al.
Publicado: (2023)

Neuronal death in Alzheimer’s disease and therapeutic opportunities
por: Donev, Rossen, et al.
Publicado: (2009)

Apolipoprotein E ε-4 as a genetic determinant of Alzheimer’s disease heterogeneity
por: Kotze, MJ, et al.
Publicado: (2015)

Apolipoprotein E: Essential Catalyst of the Alzheimer Amyloid Cascade
por: Potter, Huntington, et al.
Publicado: (2012)

Association between Alzheimer’s Disease and Apolipoprotein E Polymorphisms
por: Gozalpour, E, et al.
Publicado: (2010)

Apolipoprotein E particle size is increased in Alzheimer's disease
por: Nelson, Thomas J., et al.
Publicado: (2018)

Apolipoprotein E4 and meningeal lymphatics in Alzheimer disease: a conceptual framework
por: Mentis, Alexios-Fotios A., et al.
Publicado: (2020)

Effect of apolipoprotein E (APO E) polymorphism on leptin in Alzheimer's disease
por: Agarwal, Rachna, et al.
Publicado: (2015)

Proteolytic Cleavage of Apolipoprotein E4 as the Keystone for the Heightened Risk Associated with Alzheimer’s Disease
por: Rohn, Troy T.
Publicado: (2013)

Impact of apolipoprotein E isoforms on sporadic Alzheimer’s disease: beyond the role of amyloid beta
por: Lozupone, Madia, et al.
Publicado: (2023)

Apolipoprotein E and viral infection: Risks and Mechanisms
por: Chen, Feng, et al.
Publicado: (2023)

Serum Thioredoxin-80 is associated with age, ApoE4, and neuropathological biomarkers in Alzheimer’s disease: a potential early sign of AD
por: Goikolea, Julen, et al.
Publicado: (2022)

The influence of Apolipoprotein E genotype on regional pathology in Alzheimer’s disease
por: Sabbagh, Marwan N, et al.
Publicado: (2013)

Diagnosis Test Meta-Analysis for Apolipoprotein E in Alzheimer's Disease
por: Xiong, Xuan, et al.
Publicado: (2020)

The Important Interface Between Apolipoprotein E and Neuroinflammation in Alzheimer’s Disease
por: Kloske, Courtney M., et al.
Publicado: (2020)

Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer’s disease patients
por: Lennol, Matthew Paul, et al.
Publicado: (2022)

The Molecular Basis for Apolipoprotein E4 as the Major Risk Factor for Late-Onset Alzheimer's Disease
por: Raulin, Ana-Caroline, et al.
Publicado: (2019)

Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities
por: Zhang, Caiguo, et al.
Publicado: (2014)

Stresses in the metastatic cascade: molecular mechanisms and therapeutic opportunities
por: Shen, Minhong, et al.
Publicado: (2020)

Apolipoprotein E e4 allele is associated with extrapyramidal symptoms in Alzheimer’s disease
por: Chang, Yang-Pei, et al.
Publicado: (2019)

Role of apolipoprotein E in neurodegenerative diseases
por: Giau, Vo Van, et al.
Publicado: (2015)

Emerging Role of Ferroptosis in Diabetic Kidney Disease: Molecular Mechanisms and Therapeutic Opportunities
por: Wang, Hui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vo4s0p2reqt5g5ekdejutt2bc6